SummaryTransgenic (Tg) mice overexpressing human wild-type α-synuclein in oligodendrocytes under the control of the 2,′ 3′-cyclic nucleotide 3′-phosphodiesterase (CNP) promoter are shown here to recapitulate features of multiple system atrophy (MSA), including the accumulation of filamentous human α-synuclein aggregates in oligodendrocytes linked to their degeneration and autophagocytosis of myelin. Significantly, endogenous mouse α-synuclein also accumulated in normal and degenerating axons and axon terminals in association with oligodendroglia and neuron loss and slowly progressive motor impairments. Our studies demonstrate that overexpression of α-synuclein in oligodendrocytes of mice results in MSA-like degeneration in the CNS and that ...
The origin of α-synuclein (α-syn)-positive glial cytoplasmic inclusions found in oligodendrocytes in...
Multiple system atrophy is a progressive, neurodegenerative disease characterized by parkinsonism, a...
Multiple system atrophy is a parkinsonian neurodegenerative disorder. It is cytopathologically chara...
SummaryTransgenic (Tg) mice overexpressing human wild-type α-synuclein in oligodendrocytes under the...
Multiple system atrophy (MSA) is a rapidly progressing fatal synucleinopathy of the aging population...
AbstractMultiple system atrophy (MSA) is a rare neurodegenerative disease of undetermined cause mani...
International audienceThe synucleinopathy underlying multiple system atrophy (MSA) is characterized ...
Multiple system atrophy (MSA) is a fatal adult-onset neurodegenerative disease characterized by α-sy...
Peripheral administration (oral, intranasal, intraperitoneal, intravenous) of assembled A53T α-synuc...
Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disorder characterized by w...
Glial cytoplasmic inclusions (GCIs) containing aggregated and hyperphosphorylated α-synuclein are th...
Summary: Glial cytoplasmic inclusions (GCIs), commonly observed as α-synuclein (α-syn)-positive aggr...
α-Synucleinopathies are spreading neurodegenerative disorders characterized by the intracellular acc...
In multiple system atrophy (MSA), the protein α-synuclein misfolds into a prion conformation that se...
Multiple system atrophy (MSA) is a sporadic neurodegenerative disease manifested clinically by progr...
The origin of α-synuclein (α-syn)-positive glial cytoplasmic inclusions found in oligodendrocytes in...
Multiple system atrophy is a progressive, neurodegenerative disease characterized by parkinsonism, a...
Multiple system atrophy is a parkinsonian neurodegenerative disorder. It is cytopathologically chara...
SummaryTransgenic (Tg) mice overexpressing human wild-type α-synuclein in oligodendrocytes under the...
Multiple system atrophy (MSA) is a rapidly progressing fatal synucleinopathy of the aging population...
AbstractMultiple system atrophy (MSA) is a rare neurodegenerative disease of undetermined cause mani...
International audienceThe synucleinopathy underlying multiple system atrophy (MSA) is characterized ...
Multiple system atrophy (MSA) is a fatal adult-onset neurodegenerative disease characterized by α-sy...
Peripheral administration (oral, intranasal, intraperitoneal, intravenous) of assembled A53T α-synuc...
Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disorder characterized by w...
Glial cytoplasmic inclusions (GCIs) containing aggregated and hyperphosphorylated α-synuclein are th...
Summary: Glial cytoplasmic inclusions (GCIs), commonly observed as α-synuclein (α-syn)-positive aggr...
α-Synucleinopathies are spreading neurodegenerative disorders characterized by the intracellular acc...
In multiple system atrophy (MSA), the protein α-synuclein misfolds into a prion conformation that se...
Multiple system atrophy (MSA) is a sporadic neurodegenerative disease manifested clinically by progr...
The origin of α-synuclein (α-syn)-positive glial cytoplasmic inclusions found in oligodendrocytes in...
Multiple system atrophy is a progressive, neurodegenerative disease characterized by parkinsonism, a...
Multiple system atrophy is a parkinsonian neurodegenerative disorder. It is cytopathologically chara...